Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follitropin Alfa/Lutropin Alfa vs hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART
NCT07340827Phase 3Recruiting
- Sponsor
- Merck KGaA
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Modality
- Biologic, Hormone, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of follitropin alfa, lutropin alfa in infertility, sponsored by Merck KGaA. Started Feb 2026; status: recruiting.
02
Drugs
follitropin alfalutropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07340827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340827.